Effects of haplotypes in the interleukin 1β promoter on lipopolysaccharide-induced interleukin 1β expression

Shock

Volumn 26, Issue 1, 2006, Pages 25-30

  Wen, Ai Qing ^a   Wang, Jun ^a   Feng, Kai ^a   Zhu, Pei Fang ^a   Wang, Zheng Guo ^a   Jiang, Jian Xin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Genotype; Haplotype; Inflammation; Interleukin 1 ; Lipopolysaccharide

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; INTERLEUKIN 1;

ADULT; ARTICLE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; REPORTER GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UPREGULATION; ASIAN; BIOSYNTHESIS; CELL LINE; CHINA; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETICS; MALE; PROMOTER REGION;

ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE; CHINA; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; HAPLOTYPES; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS);

EID: 33747153368     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000223125.56888.c7     Document Type: Article

References (31)

1. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652, 1991.
2. Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 328:106-113, 1993.
3. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1-8, 1999.
4. Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B: Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42:1093-1100, 1999.
5. Moos V, Rudwaleit M, Herzog V, Hohlig K, Sieper J, Muller B: Association of genotypes affecting the expression of interleukin-1β or interleukin-1 receptor antagonist with osteoarthritis. Arthritis Rheum 43:2417-2422, 2000.
6. El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402, 2000.
7. Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS: Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 102:379-383, 1995.
8. Asai K, Hiki N, Mimura Y, Ogawa T, Unou K, Kaminishi M: Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock 16:340-343, 2001.
9. Nicklin MJ, Weith A, Dugg GW: A physical map of the region encompassing the human interleukin-1α, interleukin-1β, and interleukin-1 receptor antagonist genes. Genomics 19:382-384, 1994.
10. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW: Single base polymorphism at -511 in the human interleukin-1beta gene (IL1beta). Hum Mol Genet 1:450-454, 1992.
11. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J: A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 22:396-402, 1992.
12. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y: Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37:65-71, 2003.
13. Barber MD, Powell JJ, Lynch SF, Fearon KC, Ross JA: A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 83:1443-1447, 2000.
14. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y: Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123:1793-1803, 2002.
15. Nishimura M, Kawakami H, Komure O, Maruyama H, Morino H, Izumi Y, Nakamura S, Kaji R, Kuno S: Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord 17:808-811, 2002.
16. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S, Uchikoshi T: Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 95:1305-1311, 2000.
17. Nemetz A, Nosti-Escanilla MP, Molnar T, Kope A, Kovacs A, Feher J, Tulassay Z, Nagy F, Garcia-Gonzalez MA, Pena AS: IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 49:527-531, 1999.
18. Garcia-Gonzalez MA, Lanas A, Savelkoul PH, Santolaria S, Benito R, Crusius JB, Pena AS: Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin Exp Immunol 134:525-531, 2003.
19. Terry CF, Loukaci V, Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Bio Chem 275:18138-18144, 2000.
20. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB: Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97:10483-10488, 2000.
21. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES: High-resolution haplotype structure in the human genome. Nat Genet 29:229-232, 2001.
22. Wen AQ, Jiang JX, Zhu PF, Feng K: Linkage disequilibrium analysis of -31, -511, -1470 single nucleotide polymorphisms in the promoter of IL-1β in Chongqing population. Chin J Med Genet 21(4):412-414, 2004.
23. Schneider S, Kuefer JM, Roeslli D, et al.: Arlequin: A Software for Population Genetics Analysis, Version 1.1. Geneva, Switzerland: Genetics and Biometry Laboratories, Department of Anthropology, University of Genebra; 2000.
24. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O'Keefe GE: Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 20:218-222, 2003.
25. Heesen M, Kunz D, Bachmann-Mennenga B, Merk HF, Bloemeke B: Linkage disequilibrium between tumar necrosis factor (TNF)-a-308 G/A promoter and TNF b NcoI polymorphisms: association with TNF-a response of granulocytes to endotoxin stimulation. Crit Care Med 31:211-214, 2003.
26. Wilson AG, Symons JA, McDowell TL: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195-3199, 1997.
27. Angotti E, Mele E, Costanzo F, Avvedimento EV: A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 269:17371-17374, 1994.
28. Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Breedveld FC, Seymour AB: Correlation of polymorphic variation in the promoter region of interleukin-1beta gene with secretion of interleukin-1beta protein. Arthritis Rheum 50:1976-1983, 2004.
29. Vamvakopoulos J, Green C, Metcalfe S: Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 32:2988-2996, 2002.
30. Danis VA, Millington M, Hyland VJ, Grennan D: Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Rheumatol 99:303-310, 1995.
31. Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195-198, 1998.